NYSE:BIRK

Birkenstock (NYSE:BIRK) Faces Q2 Earnings Miss and Price Target Adjustment

Font: Financial Modeling Prep  • May 13, 2026

Market Chart
  • An analyst lowered the price target for Birkenstock to $51.00, still indicating a 54.26% upside from its trading price of $33.06.
  • Birkenstock's stock fell over 13% after missing Q2 profit estimates, with earnings per share at $0.59 against an expected $0.70.
  • Despite profitability pressures from gross margin compression (53.9% from 57.7%), Birkenstock reported strong revenue growth to $723.58 million and reaffirmed full-year 2026 targets.

Birkenstock (NYSE:BIRK), a prominent German footwear company renowned for its iconic sandals, recently saw its analyst price target adjusted. On May 13, 2026, analyst Peter McGoldrick lowered his price target for Birkenstock to $51.00. At the time, the stock was trading at $33.06, indicating that the new target still represents a potential upside of 54.26% for investors.

The market has reacted negatively to Birkenstock's recent financial performance. As highlighted by Proactiveinvestors, Birkenstock shares fell more than 13% after its second-quarter profit missed analyst estimates. The stock’s price dropped to a new 52-week low of $32.44, showing significant investor concern over its short-term results and rising inventories.

Birkenstock's latest earnings report provides further insight into this market reaction. Birkenstock announced quarterly earnings of $0.59 per share, falling short of the Zacks Consensus Estimate of $0.70 per share. This represents a negative earnings surprise of about 15.18%, a situation that occurs when a company's reported profit is significantly lower than what financial analysts had anticipated.

Profitability for Birkenstock faced pressure from several contributing factors. Gross margin, which represents the profit a company makes from selling its products before other operating costs, compressed to 53.9% from 57.7% a year earlier. This decline was primarily caused by unfavorable currency movements, higher US tariffs, and increased competition from rival brands like Crocs (NASDAQ: CROX).

Despite these challenges, Birkenstock shows signs of resilience in its overall business performance. The company posted revenues of approximately $723.58 million, a significant increase from the $604.17 million reported in the prior-year quarter. Birkenstock also reaffirmed its full-year 2026 targets, projecting revenue growth of 13% to 15% in constant currency, which effectively demonstrates underlying business performance without the impact of currency fluctuations.

Market Overview
QUCY
Mainz Biomed N.V.
$1.35
318.22%
SOXS
Direxion Daily Semiconductor Bear 3X ETF
$8.35
-6.70%
EZGO
EZGO Technologies Ltd.
$0.03
0.63%
TZA
Direxion Daily Small Cap Bear 3X ETF
$4.71
0.00%
HAO
Haoxi Health Technology Limited
$0.03
-15.23%
F
Ford Motor Company
$13.59
13.30%
WOK
WORK Medical Technology Group Ltd.
$2.76
-58.56%
WGRX
Wellgistics Health, Inc.
$0.10
23.10%
PLUG
Plug Power Inc.
$3.96
11.24%
NOK
Nokia Oyj
$14.71
11.69%